Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/18645002

Download in:

View as

General Info

PMID
18645002